We discovered that COVID-19 patients and patients with complications show unique changes in the intestinal environment, which are associated with excessive immune responses. Individual differences in the intestinal environment may contribute to the differences in susceptibility to COVID-19 and the risk of complications associated with COVID-19 among Japanese people. Individual differences in the intestinal environment may affect individual differences in vaccine efficacy and adverse reactions, and future research is expected.